In the first trimester for 2020, EFSA has published three opinions for the scientific substantiation of article 13.5 health claims. They were for:
- Coffee C21 and protection of DNA from strand breaks
- Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function
- MenaQ7® and maintenance of the elastic properties of the arteries
If you need support with your claim application and you are planning a clinical trial, our experts can support you with collecting the required scientific evidence for an EFSA conform health claim application.
